With an increase in the numbers of bacterial isolates resistant to first-line antibiotics, there has been a revival in the use of older drugs including fosfomycin. Although several commercial tests based on different...
Launch Diagnostics has increased its molecular diagnostic solution for SARS-CoV-2 with the addition of the Bosphore Novel Coronavirus (2019-nCoV) Detection kit v4 which is capable of detecting three different genes of...
Launch Diagnostics Limited is pleased to announce that Dia.Pro Diagnostic Bioprobes srl, has developed and launched four new EIA microplate kits for the detection of novel Coronavirus COVID-19 antibodies in human serum...
2020 marks the 30th anniversary of Launch Diagnostics having been in business since 1990. Launch is one of the few major independent distributors in the UK, supplying world leading diagnostic solutions to the Health...
Vircell has developed and launched two new VirClia monotest kits for the detection of novel Coronavirus COVID-19 antibodies in human serum and plasma. There are two kits available for the VirClia automated CLIA system...
Cefiderocol is a siderophore cephalosporin with a unique mechanism for penetrating efficiently into Gram-negative pathogens. Cefiderocol binds to free iron and is actively transported into bacterial cells through the...
